Literature DB >> 29522381

Experiences of burnout among drug counselors in a large opioid treatment program: A qualitative investigation.

Mark Beitel1,2, Lindsay Oberleitner1, Dharushana Muthulingam3, David Oberleitner4, Lynn M Madden1,2, Ruthanne Marcus3, Anthony Eller2,5, Madeline H Bono2,6, Declan T Barry1,2.   

Abstract

BACKGROUND: Little is known about possible experiences of burnout among drug counselors in opioid treatment programs that are scaling up capacity to address the current opioid treatment gap.
METHODS: Participants in this quality improvement study were 31 drug counselors employed by large opioid treatment programs whose treatment capacities were expanding. Experiences of burnout and approaches for managing and/or preventing burnout were examined using individual semi-structured interviews, which were audiotaped, transcribed, and systematically coded by a multidisciplinary team using grounded theory.
RESULTS: Rates of reported burnout (in response to an open-ended question) were lower than expected, with approximately 26% of participants reporting burnout. Counselor descriptions of burnout included cognitive, affective, behavioral, and physiological symptoms; and job-related demands were identified as a frequent cause. Participants described both self-initiated (e.g., engaging in pleasurable activities, exercising, taking breaks during workday) and system-supported strategies for managing or preventing burnout (e.g., availing of supervision and paid time off). Counselors provided recommendations for system-level changes to attenuate counselor risk of burnout (e.g., increased staff-wide encounters, improved communication, accessible paid time off, and increased clinical supervision).
CONCLUSIONS: Findings suggest that drug counselor burnout is not inevitable, even in opioid treatment program settings whose treatment capacities are expanding. Organizations might benefit from routinely assessing counselor feedback about burnout and implementing feasible recommendations to attenuate burnout and promote work engagement.

Entities:  

Keywords:  Buprenorphine; counselor; drug treatment center; methadone; opioid-related disorder; professional burnout

Mesh:

Year:  2018        PMID: 29522381     DOI: 10.1080/08897077.2018.1449051

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  6 in total

1.  Implementing group visits for opioid use disorder: A case series.

Authors:  Randi Sokol; Mark Albanese; Chiara Albanese; Gerard Coste; Ellie Grossman; Diana Morrill; David Roll; Amy Sobieszczyk; Zev Schuman-Olivier
Journal:  Subst Abus       Date:  2019-08-16       Impact factor: 3.716

2.  Caring for Families with Young Children Affected by Substance Use Disorder: Needed Changes.

Authors:  Elizabeth Peacock-Chambers; Davida M Schiff; Barry Zuckerman
Journal:  J Dev Behav Pediatr       Date:  2021 Jun-Jul 01       Impact factor: 2.225

3.  A qualitative investigation of addiction counselors' perceptions and experiences implementing an open-access model for treating opioid use disorder.

Authors:  Lindsay M S Oberleitner; Lynn M Madden; Dharushana Muthulingam; Ruthanne Marcus; David E Oberleitner; Mark Beitel; Marina Gaeta; Joseph F Tamberelli; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2020-11-02

4.  Implementation support for contingency management: preferences of opioid treatment program leaders and staff.

Authors:  Kelli Scott; Shelly Jarman; Samantha Moul; Cara M Murphy; Kimberly Yap; Bryan R Garner; Sara J Becker
Journal:  Implement Sci Commun       Date:  2021-04-30

5.  The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography.

Authors:  Kelli Scott; John Guigayoma; Lawrence A Palinkas; Francesca L Beaudoin; Melissa A Clark; Sara J Becker
Journal:  Addict Sci Clin Pract       Date:  2022-08-19

6.  Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.

Authors:  Randi Sokol; Mark Albanese; Aaronson Chew; Jessica Early; Ellie Grossman; David Roll; Greg Sawin; Dominic J Wu; Zev Schuman-Olivier
Journal:  Addict Sci Clin Pract       Date:  2019-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.